Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report

Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report

To follow the progression of multiple myeloma (MM) disease, serum lactate dehydrogenase (LDH) levels are as useful markers as beta-2 microglobulin and monoclonal immunoglobulin. With this study, we have presented a case of a patient with a multiple myeloma which was fulminant course, whose LDH level...

Full description

Bibliographic Details
Main Authors:	Hava Üsküdar Teke, Mustafa Başak, Deniz Teke, Mehmet Kanbay
Format:	Article
Language:	English
Published:	Galenos Publishing House 2014-02-01
Series:	Turkish Journal of Hematology
Subjects:	multiple myeloma ldh prognosis
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-87513

Similar Items

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
by: Ga-Young Song, et al.
Published: (2020-08-01)

Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels
by: Yogesh Chawla, et al.
Published: (2025-02-01)

Serum Lactate Dehydrogenase Level in Acute Leukemias
by: Mutaz Fawzi Hussain, et al.
Published: (2008-01-01)

Spinal cord involvement of multiple myeloma detected by F-18 FDG PET/CT Scan
by: İlknur Ak Sivrikoz, et al.
Published: (2010-12-01)

Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
by: Maricy Almeida Viol Ferreira Lopes, et al.
Published: (2023-04-01)

Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy
by: Man He, et al.
Published: (2021-12-01)

Lactate Dehydrogenase-A-Forming LDH5 Promotes Breast Cancer Progression
by: Fang T, et al.
Published: (2025-02-01)

Gaucher Cells or Pseudo-Gaucher Cells: That's the Question
by: Deniz Gören Şahin, et al.
Published: (2014-12-01)

Serum Levels of Lactate Dehydrogenase and Alkaline Phosphatase Enzymes in Colorectal Cancer
by: Batool Hassan Al-Ghurabi, et al.
Published: (2019-03-01)

ARE THE HIGH SERUM INTERLEUKIN-6 AND VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS AN USEFUL PROGNOSTIC MARKERS IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA PATIENTS?
by: Hava Üsküdar Teke
Published: (2014-08-01)

The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer
by: Qin Chen, et al.
Published: (2023-06-01)

Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients
by: Shuo Gu, et al.
Published: (2023-04-01)

Study Of Serum Alanine Transaminase: Serum Lactate Dehydrogenase Ratio for Typhoid Hepatitis
by: Panchsila B Damor, et al.
Published: (2016-05-01)

Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma
by: Wenke Wu, et al.
Published: (2024-12-01)

Pilot Study: Assessing the Expression of Serum Lactate Dehydrogenase and Peripheral Leukocyte Ratios in Canine Oral Malignant Melanoma
by: Ben Murray, et al.
Published: (2022-08-01)

Prognostic marker CD27 and its micro-environmental in multiple myeloma
by: Xinya Wang, et al.
Published: (2024-03-01)

Enhancing prognosis in multiple myeloma bone disease: insights from a retrospective analysis of surgical interventions
by: Xiangjun Shi, et al.
Published: (2024-12-01)

The Role of 18F-FDG-PET/CT Scan in the Management of Multiple Myeloma
by: Shirin Haghighat
Published: (2020-07-01)

A novel prognostic model based on pyroptosis-related genes for multiple myeloma
by: Cuiling Zhang, et al.
Published: (2023-02-01)

Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma
by: Gayathri Ravi, et al.
Published: (2021-01-01)

Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients
by: Byung-Hyun Lee, et al.
Published: (2021-07-01)

Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
by: Doaa A. Mohammed, et al.
Published: (2021-06-01)

Prognostic and predictive biomarker developments in multiple myeloma
by: Craig T. Wallington-Beddoe, et al.
Published: (2021-09-01)

Lactate dehydrogenase activity and total protein as diagnostic markers for cavitary effusions and identification of neoplastic effusions in dogs and cats
by: Nathália Viana Barbosa, et al.
Published: (2024-07-01)

A Report of a Symptomatic Progressive Myeloma during Pregnancy and Postpartum Period from Asymptomatic State
by: Gehad Elgabry, et al.
Published: (2023-05-01)

Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia
by: Mei-ying Wu, et al.
Published: (2020-07-01)

Myeloma /
by: 455001 Tanner, Jerome E., et al.
Published: (2008)

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
by: Sarah Sandmann, et al.
Published: (2022-07-01)

Prognostic Significance of Baseline Neutrophil Count and Lactate Dehydrogenase Level in Patients With Esophageal Squamous Cell Cancer Treated With Radiotherapy
by: He-San Luo, et al.
Published: (2020-04-01)

Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report
by: Caroline Ziegler, et al.
Published: (2021-08-01)

A study to identify novel biomarkers associated with multiple myeloma
by: Bhaskar Kalarani Iyshwarya, et al.
Published: (2023-11-01)

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2022-05-01)

Diagnostic performance of lactate dehydrogenase as a potential biomarker in predicting preeclampsia and associated factors
by: Awgichew Behaile Teklemariam, et al.
Published: (2024-05-01)

Prognostic Significance of Lactate Dehydrogenase (LDH) in COVID-19 Morbidity and Mortality
by: Rama Ibrahim
Published: (2024-10-01)

Stability of lactate dehydrogenase in plasma at different temperatures: post-analytical storage
by: López Marta Gómez, et al.
Published: (2020-10-01)

Effect of Specific Lactate Dehydrogenase Antigen from Sheep with Different Prolific Type on Hematology and Antibody Responses of Chicken
by: MY Sumaryadi, et al.
Published: (2007-01-01)

HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma
by: Jie Yang, et al.
Published: (2020-09-01)

Multiple Myeloma (Part 1) - Update on Epidemiology, Diagnostic Criteria, Systemic Treatment and Prognosis
by: Alex Guedes, et al.
Published: (2023-07-01)

Subgroup Analysis in Multiple Myeloma Patients under Sixty Years: A Single-Center Study
by: İstemi Serin, et al.
Published: (2021-02-01)

Prognostic Value of CD56 Expression in Multiple Myeloma
by: Salah Khallaf, et al.
Published: (2020-06-01)